Stephanie Ruth Edmondson

Title: The Innovative Contributions of Stephanie Ruth Edmondson

Introduction

Stephanie Ruth Edmondson is a prominent inventor based in Preston, Australia. She has made significant contributions to the field of therapeutic dendrimers, showcasing her expertise and innovative spirit. With a focus on developing advanced pharmaceutical compositions, her work has the potential to impact the treatment of various disorders, including cancers.

Latest Patents

Stephanie holds 1 patent for her invention titled "Therapeutic dendrimer." This patent describes dendrimers that consist of a core unit and five generations of building units made from lysine residues or their analogues. The dendrimers feature first terminal groups that include a cabazitazel residue covalently attached to a diglycolyl linker group, as well as second terminal groups comprising a PEG group. Additionally, her patent outlines pharmaceutical compositions that utilize these dendrimers and methods for their application in therapy for disorders such as cancers. The processes for making the dendrimers and their intermediates are also detailed in her patent.

Career Highlights

Stephanie is associated with Starpharma Pty Limited, where she continues to advance her research and development efforts. Her work at this company highlights her commitment to innovation in the pharmaceutical industry.

Collaborations

Throughout her career, Stephanie has collaborated with notable colleagues, including David James Owen and Brian Devlin Kelly. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Stephanie Ruth Edmondson's contributions to the field of therapeutic dendrimers exemplify her innovative approach to solving complex medical challenges. Her work not only enhances our understanding of dendrimer technology but also paves the way for new therapeutic options in cancer treatment.